Cargando…
Ideation and implementation of an open science drug discovery business model – M4K Pharma
M4K Pharma was incorporated to launch an open science drug discovery program that relies on regulatory exclusivity as its primary intellectual property and commercial asset, in lieu of patents.In many cases and in key markets, using regulatory exclusivity can provide equivalent commercial protection...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000 Research Limited
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346698/ https://www.ncbi.nlm.nih.gov/pubmed/30705971 http://dx.doi.org/10.12688/wellcomeopenres.14947.1 |